Expression and activity of the urokinase plasminogen activator system in canine primary brain tumors

References

• LiottaLAStetler-StevensonWGTumor invasion and metastasis: an imbalance of positive and negative regulationCancer Res199151Suppl 1850545059
   Google Scholar
• NohHHongSHuangSRole of urokinase receptor in tumor progression and developmentTheranostics20133748749523843896
   PubMed Web of Science ®Google Scholar
• DanoKAndreasenPAGrondahl-HansenKKristensenPNielsenLSSkriverLPlasminogen activators, tissue degradation and cancerAdv Cancer Res1985441392662930999
   PubMed Web of Science ®Google Scholar
• LeonardiLQuattriniIRopertoFBenassiMSProtease expression in giant cell tumour of bone: a comparative study on feline and human samplesRes Vet Sci201395231031523668898
   PubMedGoogle Scholar
• SantosALopesCMarquesRMImmunohistochemical analysis of urokinase plasminogen activator and its prognosis in canine mammary tumorsVet J20111891434820598596
   PubMed Web of Science ®Google Scholar
• KwaaanHCMazarAPMcMahonBJThe apparent uPA/PAI-1 paradox in cancer: more than meets the eyeSemin Thromb Hemost201339438239123532574
   PubMedGoogle Scholar
• CollenDLijnenHRBasic and clinical aspects of fibrinolysis and thrombolysisBlood19917812311431241742478
   PubMed Web of Science ®Google Scholar
• GilderASJonesJAHuJSoluble urokinase receptor is released selectively by glioblastoma cells that express epidermal growth factor receptor variant III and promotes tumor cell migration and invasionJ Biol Chem201529024147981480925837250
   PubMed Web of Science ®Google Scholar
• DebinskiWDickinsonPJRossmeislJHRobertsonJGiboDNew agents for targeting of IL-13RA2 expressed in primary human and canine brain tumorsPLoS One2013810e7771924147065
   PubMedGoogle Scholar
• LeBlancAKMazckoCBrownDECreation of an NCI comparative brain tumor consortium: informing the translation of new knowledge from canine to human brain tumor patientsNeuro Oncol20161891209121827179361
   PubMed Web of Science ®Google Scholar
• MohanPMChintalaSKMohanamSAdenovirus-mediated delivery of antisense gene to urokinase-type plasminogen activator suppresses glioma invasion and tumor growthCancer Res199959143369337310416596
   PubMed Web of Science ®Google Scholar
• ValleraDALiCJinNPanoskaltsis-MortariAHallWATargeting urokinase-type plasminogen activator receptor on human glioblastoma tumors with diphtheria toxin fusion protein DTATJ Natl Cancer Inst200294859760611959893
   PubMed Web of Science ®Google Scholar
• KargiotisOChettyCGogineniVuPA/uPAR downregulation inhibits radiation-induced migration, invasion, and angiogenesis in IOMM-Lee meningioma cells and decreased tumor growth in vivoInt J Oncol200833593794718949356
   PubMedGoogle Scholar
• RossmeislJHRobertsonJLZimmermanKLHigginsMAGeigerDACyclooxygenase-2 (COX-2) expression in canine intracranial meningiomasVet Comp Oncol20097317318019691646
   PubMedGoogle Scholar
• RossmeislJHJonesJCZimmermanKLRobertsonJLSurvival time following hospital discharge in dogs with palliatively treated primary brain tumorsJ Am Vet Med Assoc2013242219319823276095
   PubMedGoogle Scholar
• FaleiroMRToledoDCRodriguesMMPuPAR expression in canine normal prostate and with proliferative disordersCi Anim Bras Goiania2013142237244
   Google Scholar
• UntergasserANijveenHRaoXBisselingTGeurtsRLeunissenJAMPrimer3Plus, an enhanced web interface to Primer3Nucleic Acids Res200735W71W7417485472
   PubMed Web of Science ®Google Scholar
• AltschulSFMaddenTLSchafferAAGapped BLAST and PSI-BLAST: a new generation of protein database search programsNucleic Acids Res19972517338934029254694
   PubMed Web of Science ®Google Scholar
• KimTDSongKSLiGActivity and expression of urokinasetype plasminogen activator and matrix metalloproteinases in human colorectal cancerBMC Cancer2006621116916471
   PubMed Web of Science ®Google Scholar
• JankunJSkrzypczak-JankunEMolecular basis of specific inhibition of urokinase plasminogen activator by amilorideCancer Biochem Biophys1999171–210912310738907
   PubMedGoogle Scholar
• DickinsonPJAdvances in diagnostic and treatment modalities for intracranial tumorsJ Vet Int Med201428411651185
   PubMedGoogle Scholar
• SongRBViteCHBradleyCWCrossJRPostmortem evaluation of 435 cases of intracranial neoplasia in dogs and relationship of neoplasm with breed, age, and body weightJ Vet Intern Med20132751143115223865437
   PubMedGoogle Scholar
• SnyderJMShoferFSVan WinkleTJMassicotteCCanine intracranial primary neoplasia: 173 cases (1986–2003)J Vet Intern Med200620366967516734106
   PubMedGoogle Scholar
• ArchintiMBrittoMEdenGFurlanFMurphyRDegryseBThe urokinase receptor in the central nervous systemCNS Neurol Disord Drug Targets201110227129420874700
   PubMedGoogle Scholar
• MohanamSSawayaREYamamotoMBrunerJMNicholsonGLRaoJSProteolysis and invasiveness of brain tumors: role of urokinase-type plasminogen activator receptorJ Neurooncol19942221531607745467
   PubMed Web of Science ®Google Scholar
• VishnoiMPeddibhotlaSYinWThe isolation and characterization of CTC subsets related to breast cancer dormancySci Rep201551753326631983
   PubMedGoogle Scholar
• HirataKTamakiNuPAR as a glioma imaging targetJ Nuc Med2016572169170
   PubMedGoogle Scholar
• KimSHWanasenNPalduraiAXiaoSCollinsPLSamalSKNewcastle disease virus fusion protein is the major contributor to protective immunity of genotype-matched vaccinePLoS One201388e7402224015313
   PubMedGoogle Scholar
• ShobanaRSamalSKElankumaranSProstate-specific antigen-retargeted recombinant Newcastle disease virus for prostate cancer virotherapyJ Virol20138773792380023345509
   PubMedGoogle Scholar
• Phase I Clinical Trial of Recombinant Newcastle Disease Virus for Canine Intracranial MeningiomasVirginiaCollege of Virginia-Maryland Veterinary Medicine Available from: http://www.vetmed.vt.edu/clinical-trials/current-studies/meningioma.aspAccessed March 13, 2016
   Google Scholar